DuPont announced it has reached a definitive agreement to divest its Aramids business, including Kevlar and Nomex , to Arclin, a portfolio company of an affiliate of TJC, L.P. (TJC), in a transaction valuing the business at approximately $1.8 billion. The deal is expected to close in the first quarter of 2026, pending regulatory approvals and customary conditions.

At closing, DuPont will receive pre-tax cash proceeds of approximately $1.2 billion, a $300 million note receivable, and a non-controlling equity stake in the new Arclin company valued at $325 million, representing an estimated 17.5% ownership.

Today's announcement is another important step in our continued optimization of the new DuPont portfolio, said Lori Koch, CEO of DuPont. The transaction enhances our portfolio s growth and margin profile, provides significant upfront cash to drive shareholder value, and retains upside potential through our equity interest in Arclin.

Arclin s President and CEO Bradley Bolduc called the acquisition a transformative move: The addition of Kevlar and Nomex presents a unique opportunity to expand our scale, global reach, and innovation capabilities. Together, we will continue to deliver impactful solutions that protect people and critical infrastructure worldwide.

DuPont s Aramids business, with 1,900 employees and five manufacturing sites, generated $1.3 billion in sales in 2024 and remains the global leader in high-performance synthetic fibers. The divestiture will not affect DuPont s planned spin-off of its electronics unit, Qnity, which remains on track for November 1, 2025.

Source: www.dupont.com